President Trump sent letters to 17 pharmaceutical companies demanding that they “bring down the prices of prescription drugs in the United States to match the lowest price offered in other developed nations.” He calls it the “most-favored-nation,” or MFN, price. Trump is right that Americans generally pay more for brand-name drugs, but they also pay significantly less for most generics, […]
Author Archives: Merrill Matthews
Merrill Matthews is a resident scholar with the Institute for Policy Innovation in Dallas. He wrote this for InsideSources.com.